106454-69-7Relevant articles and documents
A rate enhancement of tert-butoxycarbonylation of aromatic amines with Boc2O in alcoholic solvents
Vilaivan, Tirayut
, p. 6739 - 6742 (2006)
A rate enhancement of tert-butoxycarbonylation of aromatic amines by Boc2O in alcohols compared to aprotic solvents was demonstrated. Kinetic analysis by NMR suggested that the reaction in CD3OD was faster than in CDCl3 by a factor of 70. Reactions between Boc2O and various aliphatic and aromatic amines in ethanol provided the N-Boc derivatives in good to excellent yields in short reaction times.
Facile synthesis of D-amino acids from an L-serine-derived aziridine
Travins, Jeremy M.,Etzkorn, Felicia A.
, p. 9389 - 9392 (1998)
Using the concept that L-serine can be converted into a desymmetrized γ-diol derivative, five D-amino acids were synthesized from a common aziridine intermediate by a general, high-yielding three-step process. The key 2-t-butyldimethylsiloxymethyl N-t-butoxycarbonyl aziridine intermediate was synthesized in four steps and 65% overall yield.
Stereoselective synthesis of 2-amino-1-hydroxy-3-phenylpropylphosphonic acid
Zygmunt, Jan,Gancarz, Roman,Lejczak, Barbara,Wieczorek, Piotr,Kafarski, Pawel
, p. 2989 - 2992 (1996)
A highly stereoselective synthesis of 2-amino-1-hydroxy-3-phenylpropylphosphonic acid was achieved by simple addition of diethyl phosphite to enantiomeric N-blocked phenylalaninals. These compounds exhibit significant herbicidal activity.
PROCESS FOR PREPARATION OF SOLRIAMFETOL AND INTERMEDIATES THEREOF
-
Page/Page column 2; 9, (2021/08/20)
The present invention relates to a process for the preparation of dopamine and norepinephrine reuptake inhibitor (DNRI) compound Solriamfetol and pharmaceutically acceptable salts thereof, having the chemical name (R)-2-amino- 3-phenylpropyl carbamate (APC) by using novel intermediates. (I)
PEPTIDE-OLIGOUREA HYBRID COMPOUNDS
-
Paragraph 00279-00280, (2020/07/31)
The present description relates to peptidomimetic foldamers, and their synthesis. In particular, the description provides peptide-amino urea hybrid peptidomimetic foldamers comprising an alpha amino acid peptide portion and an oligourea portion.